Blog - Page 3624 of 5745

WednesdayFeb 09, 2011 9:42 am

Azure Dynamics Corp. (TSX: AZD; AZDDF.PK) Signs Agreements with 76 Dealerships

Yesterday, Azure Dynamics Corp. announced that it had signed agreements with 76 auto dealerships in over 20 states across North America. These dealerships will represent and distribute Azure products such as their Transit Connect Electric and the Balance Hybrid Electric vehicles. This announcement brings the number of dealerships connected to Azure to 103. Azure Dynamics is a developer of hybrid electric/electric components and powertrain systems for commercial vehicles, such as delivery vehicles and shuttle buses. Azure works with international clients and partners, and is also represented by a now-significant number of North American dealerships. Azure is pursuing a channel distribution…

WednesdayFeb 09, 2011 9:38 am

USD Energy Corp. (UEGY.OB) Announces Name Change

Yesterday, USD Energy Corp. announced that the Company has changed their name to Casablanca Mining, Ltd. The name change is a reflection of their primary focus on gold and copper mining via their wholly owned subsidiary, Santa Teresa Minerals. “We believe the name, Casablanca Mining, Ltd., is much more representative of the company we have become as we acquire companies, properties and technologies in the mining sector,” said Zirk Engelbrecht, President. The Company is currently applying for a new trading symbol. The expectation is that the new trading symbol will be issued within the next two weeks. Casablanca Mining’s wholly…

WednesdayFeb 09, 2011 9:36 am

CytRx Corp. (CYTR) Announces Positive Results for Treatment against Bone Loss

CytRX Corp. is a biopharmaceutical company with an oncology pipeline that includes three programs in clinical development for cancer indications: bafetinib, tamibarotene and INNO-206. The company yesterday announced that results from a series of preclinical studies demonstrate bafetinib potential as a prevention method against bone loss in cancer patients who are at high risk for this event. An increase in bone resporption can cause bone deterioration. CytRX’s results showed that bafetinib significantly suppressed the level of osteoclasts and inhibited bone resorption. “The consequences of bone loss in cancer patients due to increased bone resorption can be devastating, including fractures, bone…

WednesdayFeb 09, 2011 9:14 am

Local.com Corp. (LOCM) Video Chart for Wednesday, February 9, 2011

After a fall from grace during a strong uptrend at the beginning of this year, LOCM is now holding a new-found support level at $4.00. The indicators are at a critical point to change from bearish to bullish as the price per share climbed some yesterday and now finds itself pinned against the resistance of the 20 day moving average. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

WednesdayFeb 09, 2011 9:11 am

VIASPACE Inc. (VSPC.OB) Announces Agreement with Provident Agro to Plant Giant King Grass in Indonesia

Before the opening bell today, VIASPACE Inc. and its renewable energy subsidiary VIASPACE Green Energy Inc. (OTCBB: VGREF) announced that they have signed a Memorandum of Understanding with PT Provident Agro of Jakarta Indonesia with the objective of using Giant King™ Grass as feedstock for a large scale pellet mill to manufacture a minimum of 300,000 metric tonnes per year of pellets for the export market, primarily in Europe. Owning extensive oil palm plantations and land in Sumatra, Kalimantan and Sulawesi, Indonesia with a total land bank of 150,000 hectares (370,000 acres), Provident Agro produces more than 23,500 tons of…

TuesdayFeb 08, 2011 4:58 pm

UQM Technologies, Inc. (UQM) to Supply Electric Propulsion Systems for Audi Test Fleet

UQM Technologies Inc., developer and manufacturer of power-dense, high-efficiency electric motors and products for the automotive, aerospace, military and industrial markets, today announced it will supply its PowerPhase electric propulsion systems for an Audi test-fleet build and vehicle development process for its A1 e-tron all-electric vehicle. The company noted that automobile manufacturers typically build test fleets to evaluate new technologies and vehicles that are in development stage before they are introduced on the market. Eric R. Ridenour, president and CEO of UQM, said the order reflects UQM’s ability to meet the varying demands of its automotive customers and that the…

TuesdayFeb 08, 2011 4:57 pm

Cimatron Ltd. (CIMT) Posts Solid Q4 and FY2010 Results

Cimatron Limited, a leading provider of integrated CAD/CAM solutions for the toolmaking and manufacturing industries, today announced financial results for the fourth quarter and full year 2010, posting significant increases across the board. Revenues for the fourth quarter 2010 increased 12.8 percent to $11.0 million, up from $9.8 million recorded for the fourth quarter of 2009. Full-year revenue for the 12 months ended December 31, 2010, grew 9.5 percent to $36.1 million compared to $33.0 million for the comparable 12 month-period of 2009. Cimatron reported gross profit for the fourth quarter of 2010 at $9.4 million compared to $8.0 million…

TuesdayFeb 08, 2011 3:55 pm

China Electric Motor Inc. (CELM) is “One to Watch”

China Electric Motor Inc. is a China-based company that engages in the design, production, marketing and sale of micro motor products through its subsidiaries, Shenzhen YuePengCheng Motor Co., Ltd. and Ningbo Heng Bang Long Electrical Equipment Co., Ltd. The Company's products are incorporated into consumer electronics, automobiles, power tools, toys and household appliances. Despite 48.90% year-over-year growth in revenues and continued profitability, CELM is trading at a P/E of 6.1 (the average for the industry is approximately 28). The company is also undervalued by P/S, PEG, Price/Book and Price/Cash Flow. Currently two analysts cover the stock, one with a "Strong…

TuesdayFeb 08, 2011 3:48 pm

Cytokinetics Inc. (CYTK) is “One to Watch”

Cytokinetics Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. The company's lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil (formerly CK-1827452), is in clinical development for the potential treatment of heart failure. CK-2017357, a skeletal muscle activator, is being developed by Cytokinetics independently as a potential treatment for diseases and conditions associated with aging, muscle wasting or neuromuscular dysfunction. CK-2017357 is currently the subject of a Phase IIa clinical trials program and has been…

TuesdayFeb 08, 2011 3:31 pm

STWA, Inc. (ZERO.OB) Projects Strong 2011, Outlines Technology Roadmap and Market Strategy in Shareholder Newsletter

STWA, www.stwa.com – the developers of energy efficiency technologies currently focused on two primary areas, oil pipelines and diesel fleets (via two viscosity reduction technologies), reported issuance today of a shareholder’s newsletter by the Company’s CEO, Cecil Bond Kyte, covering projected market strategy for 2011 and several key developments. The Company has developed technology which benefits every stage of the process by reducing crude oil viscosity. Thus, every phase of manipulation, from extraction to pumping the finished product through a pipeline, is improved in a way that benefits a variety of cost factors. Chief among the developments mentioned in the…

Site Search

Company Search